What type of study is this?

Evaluation of Adverse Effects After Intravenous Ferric Carboxymaltose and Iron Sucrose in the Treatment of Iron Deficiency Anemia in Pregnancy

View Full Paper

Ask AI

Bookmark

Authors

Prospective study compares adverse effects of ferric carboxymaltose and iron sucrose in pregnancy, highlighting safety profile differences.

Ferric carboxymaltose exhibited a lower rate of local adverse effects at 4.7%, compared to 7% for iron sucrose.
Out of 43 subjects, none in the ferric carboxymaltose group developed systemic reactions, while 4.7% in the iron sucrose group did.
This was a prospective study conducted on 86 antenatal women diagnosed with iron deficiency anemia.
Results suggest ferric carboxymaltose has a better safety profile in treating iron deficiency anemia in pregnancy.

Thakur et al. (2022) studied this question.

View Full Paper

Ask AI

Bookmark

Prospective study compares adverse effects of ferric carboxymaltose and iron sucrose in pregnancy, highlighting safety profile differences.